Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY30.74 CNY
Change Today +0.84 / 2.81%
Volume 12.3M
As of 3:05 AM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

china national medicines-a (600511) Snapshot

Open
CNY28.51
Previous Close
CNY29.90
Day High
CNY31.39
Day Low
CNY28.05
52 Week High
06/25/15 - CNY57.99
52 Week Low
09/5/14 - CNY24.90
Market Cap
14.7B
Average Volume 10 Days
12.0M
EPS TTM
CNY1.04
Shares Outstanding
478.8M
EX-Date
06/26/15
P/E TM
29.5x
Dividend
CNY0.10
Dividend Yield
0.33%
Current Stock Chart for CHINA NATIONAL MEDICINES-A (600511)

Related News

No related news articles were found.

china national medicines-a (600511) Related Businessweek News

No Related Businessweek News Found

china national medicines-a (600511) Details

China National Medicines Corporation Ltd. engages in the distribution of pharmaceutical products in China. It is involved in the wholesale of Chinese patent drugs, chemical preparations, chemical bulk drugs, antibiotics, biochemical products, biological products, stupefacient products, psychotropic substances and vaccines, and other products, as well as distribution of health foods. The company also provides logistics services. It operates primarily in Huainan, Anhui Province, and Beijing. China National Medicines Corporation Ltd. was founded in 1999 and is based in Beijing, China.

Founded in 1999

china national medicines-a (600511) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

china national medicines-a (600511) Key Developments

China National Medicines Corporation Ltd. Proposes Amending Some Clauses of the Articles of Association

China National Medicines Corporation Ltd. has proposed amending some clauses of the articles of association to the special shareholders' meeting to be held on September 14, 2015.

China National Medicines Corporation Ltd. Announces Unaudited Earnings Results for the Six Months Ended June 30, 2015

China National Medicines Corporation Ltd. announced unaudited earnings results for the six months ended June 30, 2015. For the period, the company reported net cash flow arising from operating activities of RMB 382,671,451.97 against RMB 177,800,225.58 a year ago. Net profit attributable to shareholders of the listed company was RMB 260,489,807.77 against RMB 244,013,449.87 a year ago. Diluted earnings per share were RMB 0.5440 against RMB 0.5096 a year ago.

China National Medicines Corporation Ltd. Approves Amendments of Articles of Association

China National Medicines Corporation Ltd. approved amending some clauses in articles of association, at the board meeting held on August 17, 2015.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600511:CH CNY30.74 CNY +0.84

600511 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600511.
View Industry Companies
 

Industry Analysis

600511

Industry Average

Valuation 600511 Industry Range
Price/Earnings 28.8x
Price/Sales 1.2x
Price/Book 5.3x
Price/Cash Flow 28.8x
TEV/Sales 1.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHINA NATIONAL MEDICINES-A, please visit www.cncm.com.cn. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.